Carr B.I.Yilmaz S.Isik B.Kutlu R.2024-08-042024-08-04202197830307873709783030787363https://doi.org/10.1007/978-3-030-78737-0_13https://hdl.handle.net/11616/92133Patients with HCC present with both their tumor and underlying liver disease, requiring input from several disciplines for optimal therapeutic decision-making. We describe our method, which emphasizes the importance of a multidisciplinary approach and a tumor board. © The Author(s), under exclusive license to Springer Nature Switzerland AG 2021. All rights reserved.eninfo:eu-repo/semantics/closedAccessMultidisciplinaryTumor boardBook Chapter22322510.1007/978-3-030-78737-0_132-s2.0-85159717831N/A